330 related articles for article (PubMed ID: 22809809)
1. An 'all-inclusive' 96-well cytochrome P450 induction method: measuring enzyme activity, mRNA levels, protein levels, and cytotoxicity from one well using cryopreserved human hepatocytes.
Halladay JS; Wong S; Khojasteh SC; Grepper S
J Pharmacol Toxicol Methods; 2012; 66(3):270-5. PubMed ID: 22809809
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous assessment of cytochrome P450 activity in cultured human hepatocytes for compound-mediated induction of CYP3A4, CYP2B6, and CYP1A2.
Rhodes SP; Otten JN; Hingorani GP; Hartley DP; Franklin RB
J Pharmacol Toxicol Methods; 2011; 63(3):223-6. PubMed ID: 21111054
[TBL] [Abstract][Full Text] [Related]
3. A multi-endpoint evaluation of cytochrome P450 1A2, 2B6 and 3A4 induction response in human hepatocyte cultures after treatment with β-naphthoflavone, phenobarbital and rifampicin.
Zhang JG; Ho T; Callendrello AL; Crespi CL; Stresser DM
Drug Metab Lett; 2010 Dec; 4(4):185-94. PubMed ID: 20583967
[TBL] [Abstract][Full Text] [Related]
4. Endosulfan induces CYP2B6 and CYP3A4 by activating the pregnane X receptor.
Casabar RC; Das PC; Dekrey GK; Gardiner CS; Cao Y; Rose RL; Wallace AD
Toxicol Appl Pharmacol; 2010 Jun; 245(3):335-43. PubMed ID: 20361990
[TBL] [Abstract][Full Text] [Related]
5. Utility of long-term cultured human hepatocytes as an in vitro model for cytochrome p450 induction.
Meneses-Lorente G; Pattison C; Guyomard C; Chesné C; Heavens R; Watt AP; Sohal B
Drug Metab Dispos; 2007 Feb; 35(2):215-20. PubMed ID: 17093007
[TBL] [Abstract][Full Text] [Related]
6. New Screening Criteria Setting on Evaluation of Cytochrome P450 Induction Using HepaRG Cells with Multiplex Branched DNA Technologies in Early Drug Discovery.
Ogasawara A; Torimoto N; Tsuda N; Aohara F; Ohashi R; Yamada Y; Taniguchi H
Drug Metab Lett; 2016; 10(3):152-160. PubMed ID: 27550199
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of autoinduction of methadone N-demethylation in human hepatocytes.
Campbell SD; Crafford A; Williamson BL; Kharasch ED
Anesth Analg; 2013 Jul; 117(1):52-60. PubMed ID: 23733841
[TBL] [Abstract][Full Text] [Related]
8. Human HepaRG Cells can be Cultured in Hanging-drop Plates for Cytochrome P450 Induction and Function Assays.
Murayama N; Usui T; Slawny N; Chesné C; Yamazaki H
Drug Metab Lett; 2015; 9(1):3-7. PubMed ID: 25600204
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of P450 inhibition and induction by artemisinin antimalarials in human liver microsomes and primary human hepatocytes.
Xing J; Kirby BJ; Whittington D; Wan Y; Goodlett DR
Drug Metab Dispos; 2012 Sep; 40(9):1757-64. PubMed ID: 22679214
[TBL] [Abstract][Full Text] [Related]
10. Efficient assessment of the utility of immortalized Fa2N-4 cells for cytochrome P450 (CYP) induction studies using multiplex quantitative reverse transcriptase-polymerase chain reaction (qRT-PCR) and substrate cassette methodologies.
Kenny JR; Chen L; McGinnity DF; Grime K; Shakesheff KM; Thomson B; Riley R
Xenobiotica; 2008 Dec; 38(12):1500-17. PubMed ID: 18989830
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of 23 lots of commercially available cryopreserved hepatocytes for induction assays of human cytochromes P450.
Yajima K; Uno Y; Murayama N; Uehara S; Shimizu M; Nakamura C; Iwasaki K; Utoh M; Yamazaki H
Drug Metab Dispos; 2014 May; 42(5):867-71. PubMed ID: 24553381
[TBL] [Abstract][Full Text] [Related]
12. Rapid determination of rat hepatocyte mRNA induction potential using oligonucleotide probes for CYP1A1, 1A2, 3A and 4A1.
Surry DD; Meneses-Lorente G; Heavens R; Jack A; Evans DC
Xenobiotica; 2000 May; 30(5):441-56. PubMed ID: 10875679
[TBL] [Abstract][Full Text] [Related]
13. Cytochrome P450 1A2 Messenger RNA is a More Reliable Marker than Cytochrome P450 1A2 Activity, Phenacetin O-Deethylation, for Assessment of Induction Potential of Drug-Metabolizing Enzymes Using HepaRG Cells.
Ogasawara A; Kato N; Torimoto N; Aohara F; Ohashi R; Yamada Y; Taniguchi H
Drug Metab Lett; 2018; 12(1):14-23. PubMed ID: 29357810
[TBL] [Abstract][Full Text] [Related]
14. Effect of bupropion on CYP2B6 and CYP3A4 catalytic activity, immunoreactive protein and mRNA levels in primary human hepatocytes: comparison with rifampicin.
Hesse LM; Sakai Y; Vishnuvardhan D; Li AP; von Moltke LL; Greenblatt DJ
J Pharm Pharmacol; 2003 Sep; 55(9):1229-39. PubMed ID: 14604466
[TBL] [Abstract][Full Text] [Related]
15. Induction of CYP2B6 and CYP3A4 expression by 1-aminobenzotriazole (ABT) in human hepatocytes.
Yang K; Koh KH; Jeong H
Drug Metab Lett; 2010 Aug; 4(3):129-33. PubMed ID: 20642445
[TBL] [Abstract][Full Text] [Related]
16. Follow-up to the pre-validation of a harmonised protocol for assessment of CYP induction responses in freshly isolated and cryopreserved human hepatocytes with respect to culture format, treatment, positive reference inducers and incubation conditions.
Abadie-Viollon C; Martin H; Blanchard N; Pekthong D; Bachellier P; Mantion G; Heyd B; Schuler F; Coassolo P; Alexandre E; Richert L
Toxicol In Vitro; 2010 Feb; 24(1):346-56. PubMed ID: 19497360
[TBL] [Abstract][Full Text] [Related]
17. Determination of cytochrome P450 1A2 and cytochrome P450 3A4 induction in cryopreserved human hepatocytes.
Roymans D; Van Looveren C; Leone A; Parker JB; McMillian M; Johnson MD; Koganti A; Gilissen R; Silber P; Mannens G; Meuldermans W
Biochem Pharmacol; 2004 Feb; 67(3):427-37. PubMed ID: 15037195
[TBL] [Abstract][Full Text] [Related]
18. Selective Suppression of CYP3A4 mRNA and Enzyme Activity by Epidermal Growth Factor in Plated Human Hepatocytes.
Zhang JG; Wang D; Ho T; Clark RJ; Stresser DM
Drug Metab Lett; 2017; 11(2):119-127. PubMed ID: 29189189
[TBL] [Abstract][Full Text] [Related]
19. Cryopreserved human hepatocytes as alternative in vitro model for cytochrome p450 induction studies.
Garcia M; Rager J; Wang Q; Strab R; Hidalgo IJ; Owen A; Li J
In Vitro Cell Dev Biol Anim; 2003; 39(7):283-7. PubMed ID: 14599235
[TBL] [Abstract][Full Text] [Related]
20. Regulation of CYP2B6 in primary human hepatocytes by prototypical inducers.
Faucette SR; Wang H; Hamilton GA; Jolley SL; Gilbert D; Lindley C; Yan B; Negishi M; LeCluyse EL
Drug Metab Dispos; 2004 Mar; 32(3):348-58. PubMed ID: 14977870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
